Evexia Lifecare Ltd
Incorporated in 1990, Evexia Lifecare Ltd does trading of Chemicals, Agriculture Produce and other Consumer Goods[1]
- Market Cap ₹ 415 Cr.
- Current Price ₹ 2.21
- High / Low ₹ 4.40 / 2.07
- Stock P/E 237
- Book Value ₹ 2.45
- Dividend Yield 0.00 %
- ROCE 0.30 %
- ROE 0.32 %
- Face Value ₹ 1.00
Pros
- Company has reduced debt.
- Stock is trading at 0.90 times its book value
- Company is expected to give good quarter
- Company's working capital requirements have reduced from 221 days to 112 days
Cons
- Though the company is reporting repeated profits, it is not paying out dividend
- The company has delivered a poor sales growth of 1.97% over past five years.
- Promoter holding is low: 3.49%
- Company has a low return on equity of 0.61% over last 3 years.
- Company has high debtors of 307 days.
- Promoter holding has decreased over last 3 years: -11.6%
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
0.62 | 33.96 | 177.53 | 74.10 | 105.42 | 100.20 | 106.63 | 75.51 | 69.55 | 56.27 | 110.48 | 94.11 | |
0.67 | 34.07 | 176.26 | 74.45 | 106.31 | 106.51 | 178.81 | 73.10 | 68.97 | 54.31 | 106.40 | 90.45 | |
Operating Profit | -0.05 | -0.11 | 1.27 | -0.35 | -0.89 | -6.31 | -72.18 | 2.41 | 0.58 | 1.96 | 4.08 | 3.66 |
OPM % | -8.06% | -0.32% | 0.72% | -0.47% | -0.84% | -6.30% | -67.69% | 3.19% | 0.83% | 3.48% | 3.69% | 3.89% |
0.43 | 0.51 | 0.16 | 1.27 | 3.48 | 11.72 | 74.35 | 0.07 | 1.88 | 0.88 | 0.14 | 0.10 | |
Interest | 0.02 | 0.05 | 0.02 | 0.02 | 0.02 | 0.21 | 0.01 | 0.10 | 0.54 | 0.49 | 1.09 | 0.47 |
Depreciation | 0.20 | 0.08 | 0.08 | 0.18 | 0.32 | 0.31 | 0.24 | 0.21 | 0.39 | 0.42 | 1.70 | 0.89 |
Profit before tax | 0.16 | 0.27 | 1.33 | 0.72 | 2.25 | 4.89 | 1.92 | 2.17 | 1.53 | 1.93 | 1.43 | 2.40 |
Tax % | 31.25% | 40.74% | 32.33% | 33.33% | 30.22% | 29.24% | 33.33% | 60.37% | 56.21% | 28.50% | 35.66% | |
0.11 | 0.16 | 0.90 | 0.48 | 1.57 | 3.47 | 1.28 | 0.86 | 0.67 | 1.38 | 0.93 | 1.75 | |
EPS in Rs | 0.00 | 0.00 | 0.01 | 0.01 | 0.03 | 0.06 | 0.02 | 0.01 | 0.01 | 0.02 | 0.00 | 0.00 |
Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Compounded Sales Growth | |
---|---|
10 Years: | 68% |
5 Years: | 2% |
3 Years: | 14% |
TTM: | 49% |
Compounded Profit Growth | |
---|---|
10 Years: | 24% |
5 Years: | -23% |
3 Years: | 3% |
TTM: | 40% |
Stock Price CAGR | |
---|---|
10 Years: | 14% |
5 Years: | -32% |
3 Years: | 7% |
1 Year: | -34% |
Return on Equity | |
---|---|
10 Years: | 1% |
5 Years: | 1% |
3 Years: | 1% |
Last Year: | 0% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 46.46 | 61.93 | 61.93 | 61.93 | 61.93 | 61.93 | 61.93 | 61.93 | 66.44 | 70.80 | 187.73 |
Reserves | 19.29 | 3.42 | 3.84 | 11.33 | 12.91 | 16.41 | 17.67 | 18.52 | 24.05 | 58.59 | 271.65 |
4.66 | 10.78 | 6.01 | 6.22 | 4.12 | 7.12 | 6.78 | 5.79 | 704.85 | 686.16 | 385.77 | |
3.59 | 35.47 | 147.02 | 128.46 | 145.51 | 138.58 | 55.79 | 40.83 | 52.16 | 67.45 | 75.22 | |
Total Liabilities | 74.00 | 111.60 | 218.80 | 207.94 | 224.47 | 224.04 | 142.17 | 127.07 | 847.50 | 883.00 | 920.37 |
2.40 | 2.28 | 2.30 | 8.90 | 8.62 | 8.94 | 8.84 | 8.96 | 10.98 | 10.72 | 49.86 | |
CWIP | 0.02 | 0.20 | 0.20 | 0.00 | 0.00 | 0.00 | 0.00 | 2.16 | 0.03 | 0.03 | 0.03 |
Investments | 3.55 | 0.51 | 0.52 | 0.01 | 0.01 | 0.01 | 0.87 | 0.87 | 704.36 | 723.79 | 716.60 |
68.03 | 108.61 | 215.78 | 199.03 | 215.84 | 215.09 | 132.46 | 115.08 | 132.13 | 148.46 | 153.88 | |
Total Assets | 74.00 | 111.60 | 218.80 | 207.94 | 224.47 | 224.04 | 142.17 | 127.07 | 847.50 | 883.00 | 920.37 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|---|---|
4.10 | 10.85 | -116.14 | -11.75 | -0.26 | -2.58 | 1.71 | -5.74 | -3.15 | 17.02 | 0.29 | |
0.22 | 2.33 | 0.55 | -5.92 | 0.02 | 0.54 | -2.43 | 7.72 | -696.62 | -17.31 | -28.93 | |
-3.64 | -12.28 | 113.19 | 17.63 | 0.42 | 1.59 | 0.77 | -0.95 | 698.70 | 0.56 | 32.03 | |
Net Cash Flow | 0.68 | 0.91 | -2.39 | -0.03 | 0.17 | -0.46 | 0.05 | 1.03 | -1.07 | 0.28 | 3.39 |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 983.15 | 237.10 | 286.42 | 173.58 | 197.42 | 248.76 | 156.37 | 73.28 | 164.47 | 282.43 | 306.95 |
Inventory Days | 197.30 | 4.70 | 1.64 | 3.03 | 2.98 | 2.27 | 11.70 | 6.96 | 11.18 | 8.00 | 11.30 |
Days Payable | 187.43 | 383.91 | 73.29 | 67.30 | 158.16 | 171.51 | 114.48 | 124.30 | 186.39 | 194.93 | 261.26 |
Cash Conversion Cycle | 993.01 | -142.11 | 214.77 | 109.31 | 42.23 | 79.52 | 53.58 | -44.05 | -10.74 | 95.49 | 56.99 |
Working Capital Days | -1,577.74 | 248.17 | 250.48 | 277.72 | 133.78 | 244.83 | 192.00 | 175.23 | 207.30 | 343.08 | 111.73 |
ROCE % | 0.44% | 1.83% | 0.98% | 2.86% | 6.20% | 2.30% | 2.63% | 0.47% | 0.30% | 0.30% |
Documents
Announcements
-
Intimation Under Reg 30 Of SEBI (LODR) Regulations, 2015
29 Aug - Evexia Lifecare fined Rs.4,73,000 by BSE (Aug 29, 2025) for board composition non-compliance.
-
Shareholder Meeting / Postal Ballot-Scrutinizer"s Report
23 Aug - Ms Krupalibahen Mehta appointed independent director; passed 99.40% (16,206,763 yes) on Aug 21, 2025.
- Shareholder Meeting / Postal Ballot-Outcome of Postal_Ballot 23 Aug
-
Intimation Of Approval Receipt From BSE Limited On Reclassification
18 Aug - BSE approved reclassification of 2,406,650 shares (0.13%) from promoters to public on Aug 18, 2025.
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
15 Aug - Published unaudited Q1 June 2025 financial results in newspapers as per SEBI norms.
Annual reports
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
-
Financial Year 2010
from bse
Business Overview:[1]
Company manufactures various petrochemical downstream products viz. special oils, special chemicals, petroleum sulphates and solvents
for industrial applications, such as rubber,
leather, ink and paint industries